| GTO ID | GTD0326 |
| Accession | E-MTAB-11315 |
| Gene therapy-related clinical trial | GTC2404 |
| Altered gene | S |
| Gene xrefs |
Gene ID:
1489668
|
| Treatment | ARCT-021(ARCT COVID-19 vaccine) |
| Control | Click to openARCT.101.1102.Day2_06;ARCT.101.1107.Day2_11;ARCT.101.2103.Day2_08;ARCT.101.2106.Day2_05;ARCT.101.2108.Day2_02;ARCT.101.2111.Day2_02;ARCT.101.3101.Day2_02;ARCT.101.3104.Day2_11;ARCT.101.4103.Day2_10;ARCT.101.4107.Day2_02;ARCT.101.4117.Day2_12;ARCT.101.4119.Day2_06;ARCT.101.5104.Day2_04;ARCT.101.5108.Day2_11;ARCT.101.5109.Day2_09;ARCT.101.5116.Day2_12;ARCT.101.6103.Day2_10;ARCT.101.6108.Day2_06;ARCT.101.6110.Day2_02;ARCT.101.6111.Day2_06;ARCT.101.7103.Day2_04;ARCT.101.7105.Day2_10;ARCT.101.7108.Day2_02;ARCT.101.7115.Day2_06;ARCT.101.8105.Day2_04;ARCT.101.8106.Day2_08;ARCT.101.8109.Day2_08;ARCT.101.8112.Day2_08 |
| Case | Click to openARCT.101.6101.Day2_02;ARCT.101.6102.Day2_06;ARCT.101.6104.Day2_02;ARCT.101.6105.Day2_06;ARCT.101.6106.Day2_10;ARCT.101.6107.Day2_02;ARCT.101.6109.Day2_10;ARCT.101.6112.Day2_10;ARCT.101.6113.Day2_02;ARCT.101.6114.Day2_06;ARCT.101.6115.Day2_10;ARCT.101.6116.Day2_02;ARCT.101.8101.Day2_12;ARCT.101.8102.Day2_04;ARCT.101.8103.Day2_08;ARCT.101.8104.Day2_12;ARCT.101.8107.Day2_12;ARCT.101.8108.Day2_04;ARCT.101.8110.Day2_12;ARCT.101.8111.Day2_04;ARCT.101.8113.Day2_12;ARCT.101.8114.Day2_04;ARCT.101.8115.Day2_08;ARCT.101.8116.Day2_12 |
| Disease | COVID-19 |
| Disease information |
Disease group: Infection Definition: A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2. Xref: DO:0080600 |
| Organism | Homo sapiens |
| Tissue/Cell type | blood |
| Characteristics | Day2;3 microgram |
| Strategy | Microarray |
| Platform | A-MTAB-668 |